Pathogenicity in mice of Staphylococcus aureus mutants deficient in exoprotein synthesis

L Odierno1, G Risatti, A Calzolari

  • 1Departmento de Microbiología, Facultad de Ciencias Exactas, Físico, Químicas y Naturales, Universidad Nacional de Río Cuarto, Argentina.

Insights

Researchers identified Staphylococcus aureus mutants with reduced virulence. Lowered virulence correlated with slower growth, and vaccination with these mutants offered partial protection against the parental strain in mice.

Area of Science:

  • Microbiology
  • Bacteriology
  • Immunology

Background:

  • Staphylococcus aureus is a significant pathogen, particularly in bovine mastitis.
  • Understanding the genetic basis of Staphylococcus aureus virulence is crucial for developing effective control strategies.

Purpose of the Study:

  • To isolate and characterize Staphylococcus aureus mutants with altered virulence.
  • To investigate the relationship between specific mutant characteristics and virulence.
  • To evaluate the potential of less virulent mutants as vaccine candidates.

Main Methods:

  • Mutagenesis of Staphylococcus aureus using ultraviolet light.
  • Isolation and characterization of twelve mutants.
  • Virulence assays in mice (intraperitoneal administration and mastitis model).
  • Growth rate determination at 37°C.
  • Vaccination studies in mice.

Main Results:

  • Twelve mutants exhibited reduced exoprotein production, altered phage type, and/or colonial morphology.
  • Mutant virulence (LD50 ratio) varied significantly (1 to 123) compared to the parental strain.
  • Lowered virulence correlated with slower growth rates at 37°C, but not with exoprotein production or morphology.
  • In the mastitis model, less virulent mutants induced less severe lesions.
  • Vaccination with two less virulent mutants increased protection against the parental strain by 11-14 fold.

Conclusions:

  • Slower growth rate is a key factor associated with reduced virulence in these Staphylococcus aureus mutants.
  • Less virulent mutants show promise as vaccine candidates for protecting against Staphylococcus aureus infections.
  • Further research is warranted to explore the mechanisms underlying growth rate-virulence correlation and to optimize vaccine strategies.

Related Concept Videos

In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...